Prelude Capital Management’s Health Assurance Acquisition Corp. Class A Common Stock HAAC Stock Holding History

Prelude Capital Management’s Portfolio HAAC Stock Details HAAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-70,000	Closed	-$699K	–	1904
2022 Q3	$699K	Buy	+70,000	New	+$696K	0.03%	529
2022 Q1	–	Sell	-52,000	Closed	-$508K	–	2464
2021 Q4	$508K	Sell	52,000 -70,774	-58%	-$694K	0.01%	993
2021 Q3	$1.2M	Sell	122,774 -77,305	-39%	-$757K	0.03%	486
2021 Q2	$2M	Buy	+200,079	New	+$2.04M	0.06%	300

Other funds holding HAAC

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Prelude Capital Management's HAAC Position: Q4 2022 in Review

Prelude Capital Management sold out of Health Assurance Acquisition Corp. Class A Common Stock (HAAC) in Q4 2022, closing a stake of 70,000 shares — an estimated $699K sold.

Prelude Capital Management first reported a position in HAAC in Q2 2021 and held it in 4 quarters. The position peaked at $2M in Q2 2021. 1 fund tracked by Wall St. Rank holds HAAC as of Q4 2022.

Prelude Capital Management reported no remaining Health Assurance Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Prelude Capital Management sold 70,000 Health Assurance Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $699K.
Prelude Capital Management first reported a position in Health Assurance Acquisition Corp. Class A Common Stock in Q2 2021 and held it in 4 quarters.
Prelude Capital Management's Health Assurance Acquisition Corp. Class A Common Stock position peaked at $2M in Q2 2021.
1 fund tracked by Wall St. Rank held Health Assurance Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.